Sökning: onr:"swepub:oai:DiVA.org:uu-19740" > Highly Active Antir...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04034naa a2200481 4500 | |
001 | oai:DiVA.org:uu-19740 | |
003 | SwePub | |
008 | 061201s2006 | |||||||||||000 ||eng| | |
009 | oai:prod.swepub.kib.ki.se:1943253 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-197402 URI |
024 | 7 | a https://doi.org/10.1097/01.qai.0000232610.93867.2f2 DOI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:19432532 URI |
040 | a (SwePub)uud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Kappert, Kai4 aut |
245 | 1 0 | a Highly Active Antiretroviral Therapy Attenuates Re-Endothelialization and Alters Neointima Formation in the Rat Carotid Artery After Balloon Injury |
264 | 1 | b Ovid Technologies (Wolters Kluwer Health),c 2006 |
338 | a print2 rdacarrier | |
520 | a Highly active antiretroviral therapy (HAART) has led to a sustained decline of HIV-associated morbidity and mortality. HAART exhibits significant side effects, however, such as hyperlipidemia and hyperglycemia, which possibly contribute to accelerated atherosclerosis in HAART-treated patients. In addition, direct effects of HAART on vascular cells have been described, which may promote atherosclerotic lesion formation. The effects of HAART on balloon-induced neointima formation have not been studied previously. The rat carotid artery balloon model was used to evaluate the effects of HAART (lopinavir, ritonavir, lamivudine, and zidovudine) on neointima formation and endothelial recovery. Furthermore, the effects of concomitant administration of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor rosuvastatin were investigated. HAART-treated animals displayed an increase in lesion size (neointima/media ratio: 1.14 +/- 0.32 vs. 1.31 +/- 0.20 in control vs. HAART; P < 0.05) and an impaired regenerative capacity of the endothelium, as indicated by reduction in endothelial regrowth from an adjacent undilated vessel segment 14 days after injury (re-endothelialization area: 8.29 +/- 1.45 mm vs. 5.09 +/- 0.53 mm in control vs. HAART; P < 0.05). When rosuvastatin was given in addition to HAART, these effects were not observed. In conclusion, HAART inhibited endothelial cell-mediated healing and promoted neointima formation after angioplasty in rats. These deleterious effects were attenuated by cotreatment with rosuvastatin, however. Our studies suggest that currently used drug regimens against HIV infection may lead to an increased risk for restenosis after percutaneous vascular interventions. Moreover, the findings indicate that the additional treatment with statins might counteract these adverse effects by HAART. | |
653 | a AIDS | |
653 | a atherosclerosis | |
653 | a highly active antiretroviral therapy | |
653 | a neointima formation | |
653 | a restenosis | |
653 | a vascular smooth muscle cell | |
653 | a MEDICINE | |
653 | a MEDICIN | |
700 | 1 | a Leppänen, Olliu Uppsala universitet,Kärlkirurgi4 aut |
700 | 1 | a Paulsson, Jannau Karolinska Institutet4 aut |
700 | 1 | a Furuhashi, Masaou Uppsala universitet,Ludwiginstitutet för cancerforskning4 aut |
700 | 1 | a Carlsson, Mari-Anneu Uppsala universitet,Kärlkirurgi4 aut0 (Swepub:uu)macarls |
700 | 1 | a Heldin, Carl-Henriku Uppsala universitet,Ludwiginstitutet för cancerforskning4 aut0 (Swepub:uu)carlheld |
700 | 1 | a Fätkenheuer, Gerd4 aut |
700 | 1 | a Rosenkranz, Stephan4 aut |
700 | 1 | a Östman, Arneu Karolinska Institutet4 aut |
710 | 2 | a Uppsala universitetb Kärlkirurgi4 org |
773 | 0 | t Journal of Acquired Immune Deficiency Syndromesd : Ovid Technologies (Wolters Kluwer Health)g 43:4, s. 383-392q 43:4<383-392x 1525-4135x 1944-7884 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-19740 |
856 | 4 8 | u https://doi.org/10.1097/01.qai.0000232610.93867.2f |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:1943253 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy